Table 2.
Perception on the meaningfulness of improvements/acquisition on the HFSME or the RULM justifying the willingness to enter a clinical study if 1, 2, or more than 2 activities are improved/acquired on the basis of the first three items scoring 0/1 in the new cohort assessed in 2022.
| Whole Cohort (N; %) | ||
|---|---|---|
|
HFMSE Acquisition from score 0 Not applicable in 11 patients |
I would not participate | 1; 0.72% |
| At least 1 activity | 83; 59.71% | |
| Two activities | 92; 66.19% | |
| More than 2 activities | 138; 99.28% | |
|
HFMSE Improvements from score 1 Not applicable in 35 patients |
I would not participate | 2; 1.74% |
| At least 1 activity | 70; 60.87% | |
| Two activities | 81; 70.43% | |
| More than 2 activities | 113; 98.26% | |
|
RULM Acquisition from score 0 Not applicable in 31 patients |
I would not participate | 1; 0.84% |
| At least 1 activity | 67; 56.30% | |
| Two activities | 77; 64.71% | |
| More than 2 activities | 118; 99.16% | |
|
RULM Improvements from score 1 Not applicable in 30 patients |
I would not participate | 1; 0.83% |
| At least 1 activity | 78; 65% | |
| Two activities | 85; 70.83% | |
| More than 2 activities | 119; 99.17% |